Description: This webcast will walk through several statistical methods for imputing race and ethnicity from U.S. datasets, highlighting their strengths and weaknesses, talking about how to use them and evaluating their accuracy, and telling you where you can get code packages as well as a free dataset to try the methods out.

Description: Expect to learn how recent advances in AI and Generative text technology can help unlock data from medical records to solve many key underwriting and actuarial challenges. Specific topics include the following: - What is NLP/AI/machine learning and how is it currently being used in underwriting? - What technological advancements have Insure Techs made in the use of AI and GPT, and how are carriers/reinsurers utilizing these enhancements? - How can you avoid some of the challenges with GPT such as Hallucinations and 'black box' outputs? - How can extraction of data from medical records assist actuaries with various pricing and analysis challenges? - What legal/compliance challenges should users be aware of and how to manage those risks?

Description: The industry sees extreme value in predictive modeling and its ability to help us meet customer demands and remain profitable, but do customers and regulators look at this as a favorable addition to our process? Hear from a dynamic panel of industry experts who will tackle a variety of issues and questions from the state of the regulatory environment to the responsibilities of the carrier.

Description: Have you ever struggled to make business decisions because your internal mortality studies lack credibility? Have you ever launched a new product or initiative and wanted to understand mortality risk before claims experience emerged? This session will discuss how predictive models can help actuaries enhance their traditional mortality studies with leading mortality leading indicators to be more nimble to market demands.

Description: EHRs are a source of digital health data that present both an opportunity and a challenge for insurers. These rapidly maturing data sources contain valuable insights and can create a faster, better applicant experience, but the costs can quickly add up. Listen to panelists discuss various use cases for EHRs, their protective value in relation to traditional underwriting approaches, and other considerations for expanding EHR use. We will take a look at how using EHRs could promote a smart ordering approach allowing us to be quicker and more cost effective, all while understanding the impact to mortality.

Description: Highlight the importance of assigning granular policyholder behavior assumptions to cohorts of a block that behave differently for universal life products. The case study assumption testing will focus on potential cash flow impacts of surrender, lapse and premium persistency behavior— individually and combined. The case study will be based on testing data related to typical demographics for a ULSG product and not on any specific company data.

Description: This session will examine bias from a social science perspective. It will discuss the three types of systemic biases using the National Institute of Standards and Technology (NIST) model. The NIST model details the three types as historical bias, societal bias, and institutionalbias. The session will also provide several examples of each type to provide a framework for identifying the social structure of bias.

Description: The rapid evolution of life insurance underwriting has created pricing and operational challenges and raised new questions about established approaches to assumption development, both of which demand a fresh perspective. As underwriting methods evolve, we find ourselves navigating uncharted territory. In this session, we delve into accelerated underwriting, focusing on two critical areas. First, we explore assumption setting in this new world, where numerous interaction effects can make it feel like we’re asked to consider everything, from every angle, all at once. Considerations for assumption setting must encompass early performance indicators—what signals inform our assumptions? Additionally, we address novel underwriting approaches and how to adapt assumptions for these paradigms. Furthermore, in the context of post-COVID claims experience, we discuss distinguishing meaningful insights from noise. Second, we examine declinable risks and their impact on mortality. In this new world ushered in by accelerated underwriting, previously excluded risks—low-frequency, high-severity declinable cases—are now part of the landscape. Quantifying their mortality impact challenges us, as historical data lacks systematic tracking. To quantify declinable risks, we draw upon research findings from analyzing 27 million life insurance applicants, providing valuable insights for attendees to navigate this dynamic landscape and make informed assumptions for pricing and risk management.

Description: The recent global pandemic, coupled with a rising interest rate environment, has emphasized the need for life insurers to be well-prepared for challenges on multiple fronts. Join industry experts in actuarial science and asset-liability management (ALM) as they discuss the significance of incorporating comprehensive pandemic modeling, mortality modeling, lapse modeling, liquidity analysis, and ALM strategies into the risk management framework of life insurance companies. Through case studies and interactive discussions, learn how to utilize systems and APIs from disparate risk models to integrate into an overall analysis to assess the short and long term impacts of the confluence of risk factors on your business, identify vulnerabilities, and implement proactive risk management strategies to enhance resilience and maintain long-term profitability.

Description: We're introducing a new “cutting edge” wealth accumulation predictive framework, the predictive equity analytics (PEA) for life products (annuity, insurance, group employer benefits, retirement plan). PEA enables life insurers and policyholders to avoid market downturns and capture returns from equities (stocks, ETFs and mutual funds) predicted to increase in next one to three trade days via fund prediction advisory by insurers, additionally by individual policyholders. The capability does not exist in insurance markets nor in financial intermediary markets.